Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
50 /100
MEDIUM RISK
Score updated Aug 28, 2026

PASG — Passage Bio, Inc. Dilution Risk Tracker

Track PASG dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track PASG — Get alerts when the score changes →

As of August 28, 2026, Passage Bio, Inc. (PASG) has a DilutionWatch DilutionScore of 50/100, rated MEDIUM dilution risk. Passage Bio, Inc. has a market capitalization of $18.51M, 3.22M shares outstanding, 1 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
85
📊 Float Risk
15
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

Watch
Minor dilution signals detected
model est. 17%
💰 Capital Raise model 35%
• Low cash runway: 4 months remaining
🔔 Track PASG — Get forecast alerts →

Market Data

Market Cap$18.51M
Shares Outstanding3.22M
Float2.89M
Cash$24.16M
Debt$5.75M
Short InterestN/A

Institutional Holdings

1 institutional holders · 135.8K shares
#1 BARCLAYS PLC 135.8K shares

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest155.8K
Days to Cover4.5
% of Float5.4%
FINRA data as of Jul 31, 2026

Recent SEC Activity

4 INSIDER TRANSACTION 2026-03-18
4 INSIDER TRANSACTION 2026-03-18
4 INSIDER TRANSACTION 2026-01-12
4 INSIDER TRANSACTION 2026-01-12
Full SEC filing analysis available with free account

Recent News

No recent news

Factual PASG Dilution Snapshot

Passage Bio, Inc. (PASG) has a DilutionScore of 50/100, rated Medium dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track PASG Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking PASG — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for PASG
PASG FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.